Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine
Open Access
- 4 March 2010
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 17 (6) , 811-814
- https://doi.org/10.1038/gt.2010.22
Abstract
The skin is potentially an excellent organ for vaccine delivery because of accessibility and the presence of immune cells. However, no simple and inexpensive cutaneous vaccination method is available. Micron-scale needles coated with DNA were tested as a simple, inexpensive device for skin delivery. Vaccination with a plasmid encoding hepatitis C virus nonstructural 3/4A protein using microneedles effectively primed specific cytotoxic T lymphocytes (CTLs). Importantly, the minimally invasive microneedles were as efficient in priming CTLs as more complicated or invasive delivery techniques, such as gene gun and hypodermic needles. Thus, microneedles may offer a promising technology for DNA vaccination.Keywords
This publication has 19 references indexed in Scilit:
- Microneedle-Based VaccinesPublished by Springer Nature ,2009
- Transdermal Influenza Immunization with Vaccine-Coated Microneedle ArraysPLOS ONE, 2009
- Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practiceExpert Review of Vaccines, 2008
- Effect of Microneedle Design on Pain in Human VolunteersThe Clinical Journal of Pain, 2008
- Microneedles permit transdermal delivery of a skin-impermeant medication to humansProceedings of the National Academy of Sciences, 2008
- Coated microneedles for transdermal deliveryPublished by Elsevier ,2006
- Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseasesMethods, 2006
- Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch systemVaccine, 2005
- DNA vaccines for biodefenceAdvanced Drug Delivery Reviews, 2005
- Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A geneGene Therapy, 2004